These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR). Ferreira JPS; Albuquerque HMT; Cardoso SM; Silva AMS; Silva VLM Eur J Med Chem; 2021 Oct; 221():113492. PubMed ID: 33984802 [TBL] [Abstract][Full Text] [Related]
23. Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer's Disease and Parkinson's Disease. Nakajima A; Ohizumi Y Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295812 [TBL] [Abstract][Full Text] [Related]
24. Biaryl scaffold-focused virtual screening for anti-aggregatory and neuroprotective effects in Alzheimer's disease. Khalid S; Zahid MA; Ali H; Kim YS; Khan S BMC Neurosci; 2018 Nov; 19(1):74. PubMed ID: 30424732 [TBL] [Abstract][Full Text] [Related]
25. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease. Han J; Du Z; Lim MH Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227 [TBL] [Abstract][Full Text] [Related]
26. Development of grape polyphenols as multi-targeting strategies for Alzheimer's disease. El Gaamouch F; Liu K; Lin HY; Wu C; Wang J Neurochem Int; 2021 Jul; 147():105046. PubMed ID: 33872681 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review. Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973 [TBL] [Abstract][Full Text] [Related]
28. Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer's disease. Schaduangrat N; Prachayasittikul V; Choomwattana S; Wongchitrat P; Phopin K; Suwanjang W; Malik AA; Vincent B; Nantasenamat C Med Res Rev; 2019 Sep; 39(5):1730-1778. PubMed ID: 30628099 [TBL] [Abstract][Full Text] [Related]
29. Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach. Ambure P; Bhat J; Puzyn T; Roy K J Biomol Struct Dyn; 2019 Mar; 37(5):1282-1306. PubMed ID: 29578387 [TBL] [Abstract][Full Text] [Related]
30. Prospective Function of Different Antioxidant Containing Natural Products in the Treatment of Neurodegenerative Diseases. Rahman MH; Akter R; Kamal MA CNS Neurol Disord Drug Targets; 2021; 20(8):694-703. PubMed ID: 32703143 [TBL] [Abstract][Full Text] [Related]
31. Anti-inflammatory Activity of Bioactive Compounds from Microalgae and Cyanobacteria by Focusing on the Mechanisms of Action. Tabarzad M; Atabaki V; Hosseinabadi T Mol Biol Rep; 2020 Aug; 47(8):6193-6205. PubMed ID: 32557174 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic Potential of Ferulic Acid in Alzheimer's Disease. Turkez H; Arslan ME; Barboza JN; Kahraman CY; de Sousa DP; Mardinoğlu A Curr Drug Deliv; 2022; 19(8):860-873. PubMed ID: 34963433 [TBL] [Abstract][Full Text] [Related]
33. Therapeutic Potential of Natural Products in Treating Neurodegenerative Disorders and Their Future Prospects and Challenges. Rahman MH; Bajgai J; Fadriquela A; Sharma S; Trinh TT; Akter R; Jeong YJ; Goh SH; Kim CS; Lee KJ Molecules; 2021 Sep; 26(17):. PubMed ID: 34500759 [TBL] [Abstract][Full Text] [Related]
34. Neuroprotective Mechanisms of Resveratrol in Alzheimer's Disease: Role of SIRT1. Gomes BAQ; Silva JPB; Romeiro CFR; Dos Santos SM; Rodrigues CA; Gonçalves PR; Sakai JT; Mendes PFS; Varela ELP; Monteiro MC Oxid Med Cell Longev; 2018; 2018():8152373. PubMed ID: 30510627 [TBL] [Abstract][Full Text] [Related]
35. Novel Multitarget Hybrid Compounds for the Treatment of Alzheimer's Disease. Michalska P; Buendia I; Del Barrio L; Leon R Curr Top Med Chem; 2017; 17(9):1027-1043. PubMed ID: 27697052 [TBL] [Abstract][Full Text] [Related]
36. Natural products as sources of new lead compounds for the treatment of Alzheimer's disease. Huang L; Su T; Li X Curr Top Med Chem; 2013; 13(15):1864-78. PubMed ID: 23931437 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and Biological Activity of Some Benzochromenoquinolinones: Tacrine Analogs as Potent Anti-Alzheimer's Agents. Mahdavi M; Hariri R; Mirfazli SS; Lotfian H; Rastergari A; Firuzi O; Edraki N; Larijani B; Akbarzadeh T; Saeedi M Chem Biodivers; 2019 Apr; 16(4):e1800488. PubMed ID: 30720917 [TBL] [Abstract][Full Text] [Related]
38. Current progresses of novel natural products and their derivatives/ analogs as anti-Alzheimer candidates: an update. Fang L; Gou S; Fang X; Cheng L; Fleck C Mini Rev Med Chem; 2013 May; 13(6):870-87. PubMed ID: 23305400 [TBL] [Abstract][Full Text] [Related]
39. New Flavone-Cyanoacetamide Hybrids with a Combination of Cholinergic, Antioxidant, Modulation of β-Amyloid Aggregation, and Neuroprotection Properties as Innovative Multifunctional Therapeutic Candidates for Alzheimer's Disease and Unraveling Their Mechanism of Action with Acetylcholinesterase. Basha SJ; Mohan P; Yeggoni DP; Babu ZR; Kumar PB; Rao AD; Subramanyam R; Damu AG Mol Pharm; 2018 Jun; 15(6):2206-2223. PubMed ID: 29745222 [TBL] [Abstract][Full Text] [Related]
40. An insight into the neuroprotective effects and molecular targets of pomegranate ( George N; AbuKhader M; Al Balushi K; Al Sabahi B; Khan SA Nutr Neurosci; 2023 Oct; 26(10):975-996. PubMed ID: 36125072 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]